Molina Healthcare (NYSE:MOH) updated its FY18 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $3.23-3.73 for the period, compared to the Thomson Reuters consensus estimate of $3.59. The company issued revenue guidance of $18.8 billion, compared to the consensus revenue estimate of $19.86 billion.
A number of research firms have recently weighed in on MOH. Leerink Swann lifted their price objective on Molina Healthcare from $100.00 to $105.00 and gave the company an outperform rating in a research report on Tuesday, January 9th. Morgan Stanley lowered their price objective on Molina Healthcare from $97.00 to $94.00 and set an overweight rating on the stock in a research report on Wednesday, February 7th. Wolfe Research raised Molina Healthcare from a market perform rating to an outperform rating in a research report on Monday, October 23rd. Zacks Investment Research cut Molina Healthcare from a strong-buy rating to a hold rating in a research report on Friday. Finally, Jefferies Group lifted their price objective on Molina Healthcare from $64.00 to $74.00 and gave the company a hold rating in a research report on Friday, November 3rd. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. Molina Healthcare has a consensus rating of Hold and a consensus target price of $71.21.
Molina Healthcare (MOH) traded down $0.05 during midday trading on Monday, reaching $78.39. The company had a trading volume of 1,585,615 shares, compared to its average volume of 1,391,621. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 1.06. Molina Healthcare has a one year low of $42.56 and a one year high of $93.98. The stock has a market cap of $4,470.00, a PE ratio of -14.86, a PEG ratio of 0.91 and a beta of 1.10.
In other news, Director John C. Molina sold 21,650 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $92.41, for a total transaction of $2,000,676.50. Following the sale, the director now directly owns 414,151 shares of the company’s stock, valued at approximately $38,271,693.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John C. Molina sold 5,385 shares of the company’s stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $92.88, for a total value of $500,158.80. Following the sale, the director now directly owns 414,151 shares in the company, valued at $38,466,344.88. The disclosure for this sale can be found here. Over the last three months, insiders sold 771,455 shares of company stock worth $61,230,420. 6.20% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: This article was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/02/12/molina-healthcare-moh-releases-fy18-earnings-guidance.html.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.